Blueprint Medicines Corp【BPMC】
| Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|
| Cash and cash equivalents | 163 | 52 | 400 | 68 | 114 | 685 | 210 | 120 | 71 | 102 |
|---|
| Marketable securities | - | 162 | 273 | 426 | 370 | 187 | 267 | 825 | 639 | 513 |
|---|
| Accounts receivable | - | - | - | - | 1 | 7 | 25 | 24 | 43 | 76 |
|---|
| Unbilled accounts receivable | 3 | 4 | - | - | 23 | 18 | 12 | 13 | 0 | 2 |
|---|
| Inventory | - | - | - | - | - | 9 | 22 | 30 | 21 | 14 |
|---|
| Prepaid expenses and other current assets | 4 | 3 | 12 | 6 | 10 | 22 | 18 | 35 | 33 | 36 |
|---|
| Total current assets | 170 | 220 | 686 | 500 | 517 | 928 | 554 | 1,047 | 808 | 743 |
|---|
| Marketable securities | - | 54 | - | - | 64 | 678 | 558 | 133 | 57 | 248 |
|---|
| Property and equipment, net | 7 | 6 | 24 | 30 | 38 | 34 | 31 | 33 | 42 | 37 |
|---|
| Operating Lease, Right-of-Use Asset | - | - | - | - | 73 | 68 | 90 | 82 | 74 | 64 |
|---|
| Restricted cash | - | - | - | 5 | 5 | 5 | 5 | 5 | 10 | 12 |
|---|
| Equity investment | - | - | - | - | - | - | - | 28 | 28 | 29 |
|---|
| Other assets | 1 | 1 | 1 | 6 | 10 | 6 | 15 | 22 | 31 | 48 |
|---|
| Total assets | 179 | 283 | 716 | 540 | 708 | 1,718 | 1,252 | 1,350 | 1,049 | 1,180 |
|---|
| Accounts payable | 2 | 2 | 4 | 3 | 5 | 4 | 8 | 3 | 5 | 7 |
|---|
| Accrued expenses | 6 | 12 | 31 | 52 | 89 | 106 | 122 | 131 | 128 | 133 |
|---|
| Operating Lease, Liability, Current | - | - | - | - | 7 | 8 | 8 | 11 | 12 | 13 |
|---|
| Current portion of deferred revenue | - | - | - | 4 | 6 | 13 | 12 | 5 | 1 | 2 |
|---|
| Other Long-Term Debt, Current | - | - | - | - | - | - | - | 17 | 39 | 62 |
|---|
| Secured Debt, Current | - | - | - | - | - | - | - | 17 | 30 | 44 |
|---|
| Total current liabilities | 19 | 29 | 43 | 60 | 106 | 131 | 150 | 183 | 215 | 261 |
|---|
| Operating Lease, Liability, Noncurrent | - | - | - | - | 89 | 82 | 103 | 93 | 82 | 69 |
|---|
| Deferred revenue, net of current portion | - | - | - | 43 | 40 | 29 | 25 | 14 | 5 | 8 |
|---|
| Other Long-Term Debt, Noncurrent | - | - | - | - | - | - | - | 413 | 402 | 194 |
|---|
| Term loan, net of current portion | - | - | - | - | - | - | - | 122 | 209 | 343 |
|---|
| Other long-term liabilities | 0 | 0 | 0 | 0 | 8 | 7 | 3 | 10 | 6 | 7 |
|---|
| Total liabilities | - | - | - | 121 | 243 | 248 | 281 | 835 | 919 | 881 |
|---|
| Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Additional paid-in capital | 279 | 421 | 980 | 1,017 | 1,412 | 2,107 | 2,250 | 2,358 | 2,474 | 2,709 |
|---|
| Accumulated other comprehensive loss | - | -0 | -0 | -0 | -3 | -5 | -4 | -10 | -3 | -4 |
|---|
| Accumulated deficit | -135 | -207 | -356 | -598 | -945 | -631 | -1,275 | -1,833 | -2,340 | -2,407 |
|---|
| Total stockholders' equity | 144 | 213 | 624 | 419 | 464 | 1,470 | 971 | 515 | 131 | 299 |
|---|
| Total liabilities and stockholders' equity | 179 | 283 | 716 | 540 | 708 | 1,718 | 1,252 | 1,350 | 1,049 | 1,180 |
|---|